Author:
Qamar Abdullah,Khan Hammad Gul,Kundi Hina,Ali Ayesha,Bashir Sumyyia,Khurshid Tooba
Abstract
Objective: This study explored the effect of simvastatin on the histomorphology of islets of Langerhans, glucose and insulin levels in rats.
Study Design: The study was a one-year laboratory-based experimental control trial.
Place and duration of study: It was conducted at Army Medical College Rawalpindi, in collaboration with the National Institute of Health Islamabad and Armed Force Institute of Pathology Rawalpindi.
Methods: A one-year, laboratory-based, two-group experimental control trial was conducted. Thirty rats were assigned to each group: a control group receiving saline injections, and a simvastatin group receiving a simvastatin 60 mg/kg/day. Histological analysis of pancreatic islets, and measurements of blood glucose and insulin levels were performed. Statistical analysis was conducted using independent sample t-tests, with significance set at p < 0.005.
Results: While simvastatin treatment did not affect the number of islets of Langerhans, The area of pancreatic islets of Langerhans was significantly higher in the simvastatin treatment group compared to control (52,664±38,871 μm2 vs 24,643±16,256 μm2, p=0.001). Serum insulin levels were also significantly elevated with simvastatin treatment (21.49±7.03 μIU/ml) compared to control (16.72±5.38 μIU/ml) (p=0.005). There were no significant differences in weekly fasting blood glucose levels at 4 or 12 weeks between groups (p>0.05). These findings suggest potential modulation of pancreatic islet function by simvastatin without affecting glycemic control in this model.
Conclusions: These findings demonstrate that simvastatin treatment significantly impacts the morphology and function of pancreatic islets in rats, increasing insulin secretion without affecting blood glucose levels. Further research is necessary to elucidate the underlying mechanisms and clinical implications of these observations.
Keywords: Simvastatin, islets of Langerhans, Sprague-Dawley rats, insulin, glucose, pancreas.
Publisher
Rawalpindi Medical University
Reference18 articles.
1. Thiruvengadam NR, Schaubel DE, Forde K, Lee P, Saumoy M, Kochman ML. Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis. Clinical Gastroenterology and Hepatology. 2022. DOI:10.1016/j.cgh.2022.05.017.
2. Ashrafizadeh H, Oroojan AA, Ahmadi I, An'aam M. The Role of Statins (HMG-CoA Reductase Inhibitors) on Insulin Secretion from the Islets of Langerhans: A Systematic Review. Jentashapir Journal of Cellular and Molecular Biology. 2022;13(2). DOI:10.5812/jjcmb-129634
3. Ward NC, Watts GF, Eckel RH. Statin toxicity: mechanistic insights and clinical implications. Circulation research. 2019;124(2):328-50. DOI:10.1161/CIRCRESAHA.118.312782
4. Shen L, Gu Y, Qiu Y, Cheng T, Nie A, Cui C, et al. Atorvastatin Targets the Islet Mevalonate Pathway to Dysregulate mTOR Signaling and Reduce β-Cell Functional Mass. Diabetes. 2020;69(1):48-59.DOI: 10.2337/db19-0178.
5. Qamar A, Hashmi SN, Mushtaq F. Simvastatin Induced Histomorphological changes in skeletal muscle fiber of rats and protective effect of formoterol coadministration. Pakistan Armed Forces Medical Journal. 2019;69(3):605-10. ISSN Online: 2411-8842 Print: 0030-9648